Paper39257585
The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.
McCann N and 3 others. Front Immunol, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines. Papers, record 39257585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39257585
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Salmonella Vaccines | Major topic |
| Salmonella Infections | Major topic |
| Humans | |
| Salmonella typhi | |
| Vaccination | |
| Vaccine Efficacy | |
| Typhoid Fever | |
| Salmonella |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32968012 | Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G. | mSphere | 2020 | https://conductscience.org/library/papers/32968012 | PubMed |
| 2 | 9607841 | Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9607841 | PubMed |
| 3 | 23593253 | Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial. | PLoS One | 2013 | https://conductscience.org/library/papers/23593253 | PubMed |
| 4 | 6028241 | Appraisal of typhoid vaccine in experimentally infected human subjects. | Trans Am Clin Climatol Assoc | 1967 | https://conductscience.org/library/papers/6028241 | PubMed |
| 5 | 4916913 | Typhoid fever: pathogenesis and immunologic control. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4916913 | PubMed |
| 6 | 38199617 | Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK. | BMJ Open | 2024 | https://conductscience.org/library/papers/38199617 | PubMed |
| 7 | 28965718 | Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. | Lancet | 2017 | https://conductscience.org/library/papers/28965718 | PubMed |
| 8 | 1538539 | Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. | JAMA | 1992 | https://conductscience.org/library/papers/1538539 | PubMed |
| 9 | 12228290 | Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans. | Infect Immun | 2002 | https://conductscience.org/library/papers/12228290 | PubMed |
| 10 | 34714686 | Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34714686 | PubMed |
| 11 | 35921476 | Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35921476 | PubMed |
| 12 | 2669099 | Progress in vaccines against typhoid fever. | Rev Infect Dis | 1989 | https://conductscience.org/library/papers/2669099 | PubMed |
| 13 | 6966763 | Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6966763 | PubMed |
| 14 | 30849494 | Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902. | Clin Immunol | 2019 | https://conductscience.org/library/papers/30849494 | PubMed |
| 15 | 4916916 | Typhoid fever: pathogenesis and immunologic control. 2. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4916916 | PubMed |
| 16 | 37225278 | Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers. | BMJ Open | 2023 | https://conductscience.org/library/papers/37225278 | PubMed |
| 17 | 37589596 | Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso. | J Pediatric Infect Dis Soc | 2023 | https://conductscience.org/library/papers/37589596 | PubMed |
| 18 | 29387052 | Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model. | Front Immunol | 2017 | https://conductscience.org/library/papers/29387052 | PubMed |
| 19 | 37402153 | Molecular correlates of vaccine-induced protection against typhoid fever. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37402153 | PubMed |
| 20 | 1498769 | Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. | Clin Microbiol Rev | 1992 | https://conductscience.org/library/papers/1498769 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41471961 | Characterization of a Luminescence-Based Serum Bactericidal Activity Assay for Human Sera Against a Panel of Salmonella Strains. | Microorganisms | 2025 | https://conductscience.org/library/papers/41471961 | PubMed |
| 40318346 | Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries. | Vaccine | 2025 | https://conductscience.org/library/papers/40318346 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39257585
GET https://conductscience.org/api/papers/v1/39257585/references?page=2